Morriss, Richard K, Robson, Michael J, Deakin, J F William · Psychopharmacology · 2002 · DOI
This study tested whether people with ME/CFS have unusually sensitive brain receptors that respond to a hormone-like drug called clonidine. Researchers gave 10 ME/CFS patients and 10 healthy controls either clonidine or a placebo while they performed stressful thinking tasks, and measured their hormones, blood pressure, and thinking speed. ME/CFS patients showed slightly stronger hormone responses to clonidine and were faster at starting a planning task, suggesting their brains may react more strongly to stress-related chemical signals.
Understanding the neurochemical basis of ME/CFS cognitive symptoms could identify new treatment targets and explain why concentration and memory problems worsen under stress. This study provides experimental evidence linking abnormal brain receptor function to ME/CFS, potentially opening doors to receptor-based therapeutics and validating patients' subjective cognitive complaints as having biological underpinnings.
This study does not prove that clonidine itself would treat ME/CFS cognitive symptoms—in fact, most cognitive measures did not improve despite the receptor sensitivity. The findings show a biological difference in receptor function but do not establish that this directly causes concentration and memory problems, nor do they demonstrate clinical benefit from targeting these receptors. Small sample size (n=10) limits generalizability.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →